Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Launched by STANFORD UNIVERSITY · Aug 22, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer, is focused on collecting biological samples (like blood or tissue) from two groups of patients: those who have pancreatic cysts and those who are at high risk for developing pancreatic cancer. High risk is defined as having a family history of the disease or specific genetic mutations. The goal of this study is to gather important information that could help doctors find pancreatic cancer earlier, which can improve treatment options and outcomes.
To be eligible for this trial, you need to be at least 18 years old and either have a pancreatic cyst or be identified as high risk for pancreatic cancer. Participants will be asked to provide consent and donate biological samples, which will be used for research purposes. The trial is currently recruiting participants of all genders, and it's an important opportunity for those affected by pancreatic health issues to contribute to research that could benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older than 18 with pancreas cyst
- • Older than 18 at high risk for Pancreas cancer
- Exclusion Criteria:
- • Unable to provide consent
- • Not willing to provide bio-specimens
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Walter Park, MD
Principal Investigator
Faculty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials